Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy

European Journal of Cancer Care

Volumn 17, Issue 2, 2008, Pages 174-181

  Liu, M T ^a,b,c,d   Hsu, J C ^a   Liu, W S ^c   Wang, A Y ^d   Huang, W T ^a   Chang, T H ^d   Pi, C P ^a   Huang, C Y ^b   Huang, C C ^a   Chou, P H ^a   Chen, T H ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d YUANPEI UNIVERSITY   (Taiwan)

Author keywords

Adjuvant chemoradiotherapy; Adjuvant radiotherapy; Cervical cancer; Prognostic factors

Indexed keywords

EID: 39749148920     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2007.00831.x     Document Type: Article

References (43)

1. Alvarez R.D., Soong S.J., Kinney W.K., Reid G.C., Schray M.F. & Podratz K.C. (1989) Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early‐stage squamous carcinoma of the cervix. Gynecologic Oncology 35, 130–135.
2. Aoki Y., Sasaki M., Watanabe M., Sato T., Tsuneki I., Aida H. & Tanaka K. (2000) High‐risk group in node‐positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecologic Oncology 77, 305–309.
3. Atlan D., Touboul E., Deniaud‐Alexandre E., Lefranc J.P., Antoine J.M., Jannet D., Lhuillier P., Uzan M., Huart J., Genestie C., Antoine M., Jamali M., Ganansia V., Milliez J., Uzan S. & Blondon J. (2002) Operable stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy. International Journal of Radiation Oncology, Biology, Physics 54, 780–793.
4. Barber B.R., Sommers S.C., Rotterdam H. & Kwon T. (1978) Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstetrics and Gynecology 52, 343–348.
5. Berman M.L., Bergen S. & Salazar H. (1990) Influence of histological features and treatment on the prognosis of patients with cervical cancer metastatic to pelvic lymph nodes. Gynecologic Oncology 39, 127–131.
6. Bloss J.D., Berman M.L., Mukhererjee J., Manetta A., Emma D., Ramsanghani N.S. & DiSaia P.J. (1992) Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecologic Oncology 47, 21–27.
7. Bonomi P., Blessing J., Ball H., Hanjani P. & DiSaia P.J. (1989) A phase II evaluation of cisplatin and 5‐Fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecologic Oncology 34, 357–359.
8. Burke T.W., Hoskins W.J., Heller P.B., Bibro M.C., Weiser E.B. & Park R.C. (1987) Prognostic factors associated with radical hysterectomy failure. Gynecologic Oncology 26, 153–159.
9. Cox J.D., Stetz J. & Pajak T.F. (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology, Biology, Physics 31, 1341–1346.
10. Curtin J.P., Hoskins W.J., Venkatraman E.S., Almadrones L., Podratz K.C., Long H., Teneriello M., Averette H.A. & Sevin B.U. (1996) Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high‐risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH‐PLND): a randomized phase III trial. Gynecologic Oncology 61, 3–10.
11. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T. & Major F. (1990) Prospective surgical‐pathological study of disease‐free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecologic Oncology 38, 352–357.
12. Eifel P.J., Winter K., Morris M., Levenback C., Grigsby P.W., Cooper J., Rotman M., Gershenson D. & Mutch D.G. (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para‐aortic irradiation for high‐risk cervical cancer: an update of Radiation Therapy Oncology Group Trial (RTOG) 90–01. Journal of Clinical Oncology 22, 872–880.
13. Fuller A.F., Elliott N., Kosloff C. & Lewis J.L. (1982) Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment. Gynecologic Oncology 13, 165–174.
14. Fuller A.F., Elliott N., Kosloff C., Hoskins W.J. & Lewis J.L. (1989) Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecologic Oncology 33, 34–39.
15. Green J.A., Kirwan J.M., Tierney J.F. & Symonds P. (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta‐analysis. Lancet 358, 781–786.
16. Grigsby P.W. (2001) Cervical cancer: combined modality therapy. Cancer Journal 7, 47–50.
17. Havrilesky L.J., Leath C.A., Huh W., Calingaert B., Bentley R.C., Soper J.T. & Alvarez Secord A. (2004) Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecologic Oncology 93, 429–434.
18. Hopkins M.P. & Morley G.W. (1991a) Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival. American Journal of Obstetrics and Gynecology 164, 1520–1529.
19. Hopkins M.P. & Morley G.W. (1991b) Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer 68, 272–277.
20. Inoue T. & Morita K. (1990) The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 65, 1923–1927.
21. Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., Akazawa K. & Nakano H. (1992) Multivariate analysis of the histopathological prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 69, 181–186.
22. Kim R.Y., Salter M.M. & Shingleton H.M. (1988) Adjuvant postoperative radiation therapy following radical hysterectomy in stage IB carcinoma of the cervix‐analysis of treatment failure. International Journal of Radiation Oncology, Biology, Physics 14, 445–449.
23. Kinney W.K., Alvarez R.D., Reid G.C., Schray M.F., Soong S.J., Morley G.W., Podratz K.C. & Shingleton H.M. (1989) Value of adjuvant whole‐pelvis irradiation after Wertheim hysterectomy for early‐stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched‐control study. Gynecologic Oncology 34, 258–262.
24. Kodaira T., Fuwa N., Nakanishi T., Kuzuya K., Sasaoka M., Furutani K. & Kamata M. (2002) Retrospective analysis of postoperative radiotherapy for node‐negative cervical carcinoma with stage IB–IIB disease. Japanese Journal of Clinical Oncology 32, 255–261.
25. Lai C.H., Chang H.C., Chang T.C., Hsueh S. & Tang S.G. (1993) Prognostic factors and impacts of adjuvant therapy in early‐stage cervical carcinoma with pelvic node metastases. Gynecologic Oncology 51, 390–396.
26. Lai C.H., Hong J.H., Hsueh S., Ng K.K., Chang T.C., Tseng C.J., Chou H.H. & Huang K.G. (1999) Preoperative prognostic variables and the impact of adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 85, 1537–1546.
27. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., Favini G., Ferri L. & Mangioni C. (1997) Randomised study of radical surgery versus radiotherapy for stage Ib‐IIa cervical cancer. Lancet 350, 535–540.
28. Monk B.J., Cha D.S., Walker J.L., Burger R.A., Ramsinghani N.S., Manetta A., DiSaia P.J. & Berman M.L. (1994) Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecologic Oncology 54, 4–9.
29. Nakanishi T., Ishikawa H., Suzuki Y., Inoue T., Nakamura S. & Kuzuya K. (2000) A comparison of prognoses of pathologic stage IB adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecologic Oncology 79, 289–293.
30. Omura G.A. (1996) Chemotherapy for stage IVB or recurrent cancer of the uterine cervix. Journal of the National Cancer Institute 21, 123–126.
31. Peters W.A., Liu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.S., Souhami L., Grigsby P., Gordon W. Jr. & Alberts D.S. (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high‐risk early‐stage cancer of the cervix. Journal of Clinical Oncology 18, 1606–1613.
32. Piver M.S. & Chung W.S. (1975) Prognostic significance of cervical lesion size and pelvic node metastasis in cervical carcinoma. Obstetrics and Gynecology 46, 507–510.
33. Samlal R.A., Van Der Velden J., Ten Kate F.J., Schilthuis M.S., Hart A.A. & Lammes F.B. (1997) Surgical pathological factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer 80, 1234–1240.
34. Sedlis A., Bundy B.N., Rotman M.Z., Lentz S.S., Muderspach L.I. & Zaino R.J. (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecologic Oncology 73, 177–183.
35. Sevin B.U., Lu Y., Bloch D.A., Nadji M., Koechli O.R. & Averette H.E. (1996) Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 78, 1438–1446.
36. Soisson A.P., Soper J.T., Clarke‐Pearson D.L., Berchuck A., Montana G. & Creasman W.T. (1990) Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecologic Oncology 37, 390–395.
37. Stock R.G., Chen A.S.J., John C., Flickinger J.C., Kalnicki S. & Seski J. (1995) Node‐positive cervical cancer: impact of pelvic irradiation and patterns of failure. International Journal of Radiation Oncology, Biology, Physics 31, 31–36.
38. Uno T., Ito H., Itami J., Yasuda S., Isobe K., Hara R., Sato T., Minoura S., Shigematsu N. & Kubo A. (2000) Postoperative radiation therapy for stage IB‐IIB carcinoma of the cervix with poor prognostic factors. Anticancer Research 20, 2235–2240.
39. Van Der Velden J., Samlal R., Schilthuis M.S., Gonzalez D.G., Ten Kate F.J.W. & Lammes F.B. (1999) A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi Radical Hysterectomy for cervical cancer confined to the cervix. Gynecologic Oncology 75, 233–237.
40. Volterrani F., Feltre L., Sigurta D., Giuseppe M. & Luciani L. (1983) Radiotherapy versus surgery in the treatment of cervix stage IB cancer. International Journal of Radiation Oncology, Biology, Physics 9, 1781–1784.
41. Weiss G.R., Green S., Hannigan E.V., Boutselis J.G., Surwit E.A. & Alberts D.S. (1990) A phase II trial of cisplatin and 5‐fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a southwest oncology group trial. Gynecologic Oncology 37, 354–358.
42. Yuan C., Wang P., Lai C., Tsu E., Yen M. & Ng H. (1999) Recurrence and survival analysis of 1,115 cervical cancer patients treated with radical hysterectomy. Gynecologic and Obstetric Investigation 47, 127–132.
43. Zreik T.G., Chambers J.T. & Chambers S.K. (1996) Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstetrics and Gynecology 87, 741–746.